Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Duncan Disease

fluorodeoxyglucose f18 has been researched along with Duncan Disease in 53 studies

Research

Studies (53)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's13 (24.53)29.6817
2010's25 (47.17)24.3611
2020's15 (28.30)2.80

Authors

AuthorsStudies
Tong, C; Zhuang, H1
Feng, L; Lu, X; Wang, W; Yang, J; Yang, X1
Dobashi, H; Kadowaki, N; Kameda, T; Kato, M; Mino, R; Mitamura, K; Miyagi, T; Mizusaki, M; Nakashima, S; Norikane, T; Shimada, H; Sugihara, K; Wakiya, R; Yamamoto, Y1
Chow, TK1
Arii, K; Matumoto, M; Okamoto, T; Shinohara, T; Sumitomo, K1
Cai, L; Chen, Y; He, X; Shu, Q1
Fleury, AS; Zhuang, H1
Diepstra, A; Dierckx, RAJO; Glaudemans, AWJM; Huls, G; Kahle, XU; Kwee, TC; Montes de Jesus, FM; Nijland, M; Noordzij, W; Rosati, S; van der Bij, W; van Meerten, T; Verschuuren, EAM1
Ceriani, L; Treglia, G1
Kim, DH; Kim, SJ1
Amarelli, C; Belfiore, MP; Cappabianca, S; Casale, B; Ciccozzi, M; Creta, M; DE Rimini, ML; Maiello, C; Reginelli, A; Sagnelli, C; Sagnelli, E; Sica, A; Spada, A; Troiani, T1
de Vries, EGE; Diepstra, A; Glaudemans, AWJM; Jorritsma-Smit, A; Kahle, XU; Kwee, TC; Lub-de Hooge, MN; Montes de Jesus, FM; Nijland, M; Noordzij, W; Plattel, WJ; van den Berg, A; van Meerten, T1
Xu, YF; Yang, JG1
Borrego Dorado, I; Fernández López, R; Fernández-Rodríguez, P; Piñero González de la Peña, P; Tamayo Carabaño, D1
Guja, KE; Iagaru, A; Song, H1
Arai, A; Imadome, KI; Miura, O; Nakadate, M; Tateishi, U; Toriihara, A; Yamamoto, K1
Braubach, P; Derlin, T; Hueper, K; Kreipe, HH1
Amthauer, H; Denecke, T; Dreyling, MH; Franzius, C; Kneba, M; Reinke, P; Riess, H; Subklewe, M; Trappe, RU; Zimmermann, H1
Kan, Y; Liu, J; Wang, W; Yang, J; Yang, Y1
Dong, A; Dong, H; Wang, Y; Zhong, X1
Noy, A; Riedl, C; Ulaner, G; Ward, J1
Demir, E; Karaoglan, C; Sair, B; Sever, MS; Turkmen, A; Yazici, H; Yegen, G1
Acevedo Báñez, I; Borrego Dorado, I; de Bonilla Damiá, Á; Fernández-Rodríguez, P1
Anten, S; Arntzenius, AB; Binnerts, A; Comans, EF; Gompelman, M; Lensen, KJ; Siegert, CE; Smit, F; Smulders, YM; Stam, F; van der Laken, CJ; van Paassen, AQ; van Schaardenburg, D; Voerman, BJ; Voskuyl, AE; Zant, FM; Zwijnenburg, T1
Ardeshna, K; Bomanji, J; Panagiotidis, E; Pencharz, D; Quigley, AM; Sajjan, R; Syed, R1
Shapiro, NL; Sidell, D; Venick, RS1
Iagaru, A; Mittra, E; Mosci, C; Quon, A; Takehana, CS; Twist, CJ1
Bai, X; Yang, H; Zhuang, H1
Huh, JR; Jo, KW; Kim, MY; Shim, TS; Yoon, GY1
Bajno, L; Moineddin, R; Punnett, A; Shammas, A; Vali, R1
Lo, G; Metser, U1
Hattori, N; Hirata, K; Kikuchi, Y; Kobayashi, K; Manabe, O; Oyama-Manabe, N; Tamaki, N; Toyonaga, T; Watanabe, S1
Almusa, O; Daly, B; Shreve, P1
Barker, R; Bower, M; Chinn, R; Kazmi, F; Nelson, M; Ngan, S; O'Doherty, M; Stebbing, J1
Bradley, KM; Chowdhury, FU; Gleeson, FV; Sheerin, F1
Araki, O; Chida, M; Honma, K; Karube, Y; Kobayashi, S; Miyoshi, S1
Kataoka, K; Kurokawa, M; Ota, S; Seo, S; Takahashi, T1
Katayama, M; Kubota, T; Moritani, S; Terasaki, H1
Ariyoshi, K; Matsunaga, N; Nakazora, T; Suga, K; Yasuhiko, K; Yujiri, T1
Hirata, K; Imamura, M; Kuramoto, R; Oridate, N; Suzuki, S; Takei, T; Tamaki, N; Yamada, Y1
Choi, BW; Kim, HW; Kim, SH; Kim, SJ; Won, KS; Zeon, SK1
Shin, YM1
Gogbashian, A; Lambert, J; Sanghera, B; Sonoda, LI; Wong, WL1
Brepoels, L; De Wolf-Peeters, C; Dierickx, D; Dupont, L; Gheysens, O; Herreman, A; Kuypers, D; Morscio, J; Nevens, F; Pirenne, J; Requilé, A; Sagaert, X; Tousseyn, T; Uyttebroeck, A; Van Cleemput, J; Verhoef, G; Verscuren, R; Wlodarska, I1
Chang, YL; Kao, CH; Pan, MH; Wu, YW; Yen, RF1
Butnor, KJ; Coleman, RE; Marom, EM; McAdams, HP1
Franc, BL; O'Conner, AR1
Aoyama, A; Fukuse, T; Hanaoka, N; Koyama, T; Saga, T; Tachibana, M; Tamai, K; Togashi, K; Umeoka, S; Wada, H1
Avila, N; Bacharach, SL; Carrasquillo, JA; Chen, CC; Dale, JK; Dugan, F; Fleisher, T; Jaffe, ES; Puck, JM; Rao, VK; Straus, SE; Tretler, J; Whatley, M; Wilson, W1
Bakker, NA; van Imhoff, GW; van Son, WJ; Verschuuren, EA1
Boerner, AR; Galanski, M; Klein, C; Knapp, WH; Maecker, B; Schirg, E; von Falck, C1
Franceschetti, S; Gaidano, G; Ramponi, A; Rossi, D; Stratta, P1
Bianchi, E; Delaloye, AB; Duchosal, MA; Nicod, M; Pascual, M1

Reviews

6 review(s) available for fluorodeoxyglucose f18 and Duncan Disease

ArticleYear
Diagnostic performances of F-18 FDG PET or PET/CT for detection of post-transplant lymphoproliferative disorder: a systematic review and meta-analysis.
    Nuclear medicine communications, 2020, Volume: 41, Issue:6

    Topics: Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymphoproliferative Disorders; Positron Emission Tomography Computed Tomography

2020
Molecular imaging in lymphoma beyond
    The Lancet. Haematology, 2020, Volume: 7, Issue:6

    Topics: Biomarkers, Tumor; Clinical Trials as Topic; Fluorodeoxyglucose F18; Humans; Immunotherapy; Lymphoma; Lymphoproliferative Disorders; Molecular Imaging; Neoplasm Staging; Positron-Emission Tomography; Precision Medicine; Radioimmunotherapy; Radioisotopes; Tissue Distribution

2020
Roles of F-18-Fluoro-2-Deoxy-Glucose PET/Computed Tomography Scans in the Management of Post-Transplant Lymphoproliferative Disease in Pediatric Patient.
    PET clinics, 2020, Volume: 15, Issue:3

    Topics: Adolescent; Child; Child, Preschool; Fluorodeoxyglucose F18; Humans; Lymphoproliferative Disorders; Pediatrics; Positron Emission Tomography Computed Tomography; Postoperative Complications; Radiopharmaceuticals; Transplants

2020
    Seminars in nuclear medicine, 2021, Volume: 51, Issue:4

    Topics: Child; Epstein-Barr Virus Infections; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Lymphoproliferative Disorders; Multicenter Studies as Topic; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography

2021
FDG-PET/CT in abdominal post-transplant lymphoproliferative disease.
    The British journal of radiology, 2016, Volume: 89, Issue:1057

    Topics: Abdomen; Fluorodeoxyglucose F18; Humans; Lymphoproliferative Disorders; Multimodal Imaging; Organ Transplantation; Positron-Emission Tomography; Postoperative Complications; Radiography, Abdominal; Radiopharmaceuticals; Stem Cell Transplantation; Tomography, X-Ray Computed

2016
Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation.
    Transplant international : official journal of the European Society for Organ Transplantation, 2007, Volume: 20, Issue:3

    Topics: Cytomegalovirus Infections; DNA, Viral; Epstein-Barr Virus Infections; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Immunosuppression Therapy; Interleukin-10; Lymphoproliferative Disorders; Organ Transplantation; Positron-Emission Tomography; Postoperative Complications; Risk Factors; Time Factors

2007

Trials

1 trial(s) available for fluorodeoxyglucose f18 and Duncan Disease

ArticleYear
Fluorodeoxyglucose positron emission tomography (FDG-PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS).
    American journal of hematology, 2006, Volume: 81, Issue:2

    Topics: Autoimmune Diseases; Biopsy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Diseases; Lymphoma; Lymphoproliferative Disorders; Male; Mutation; Positron-Emission Tomography; Prospective Studies

2006

Other Studies

46 other study(ies) available for fluorodeoxyglucose f18 and Duncan Disease

ArticleYear
Increased Genioglossus Muscle FDG Activity Due to Using Pacifier.
    Clinical nuclear medicine, 2022, Jul-01, Volume: 47, Issue:7

    Topics: Female; Fluorodeoxyglucose F18; Humans; Infant; Lymphoproliferative Disorders; Muscles; Pacifiers; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed

2022
Solitary Central Nervous System Relapse of Posttransplant Lymphoproliferative Disorder on 18 F-FDG PET/CT.
    Clinical nuclear medicine, 2022, 11-01, Volume: 47, Issue:11

    Topics: Adult; Central Nervous System; Female; Fluorodeoxyglucose F18; Humans; Lymphoproliferative Disorders; Positron Emission Tomography Computed Tomography; Recurrence

2022
FDG-PET/CT imaging parameters for predicting spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis.
    Scientific reports, 2022, 09-13, Volume: 12, Issue:1

    Topics: Arthritis, Rheumatoid; Fluorodeoxyglucose F18; Humans; Lymphoproliferative Disorders; Methotrexate; Positron Emission Tomography Computed Tomography

2022
Hepatic Superscan in Methotrexate-Associated Lymphoproliferative Disorder.
    Clinical nuclear medicine, 2023, Jun-01, Volume: 48, Issue:6

    Topics: Adult; Fluorodeoxyglucose F18; Humans; Liver; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Positron Emission Tomography Computed Tomography

2023
Slowly Expanding 18 F-FDG PET-Positive Irregular Opacities in the Lung Due to Diffuse Lymphoid Hyperplasia Preceding Rheumatoid Arthritis.
    Clinical nuclear medicine, 2023, Jun-01, Volume: 48, Issue:6

    Topics: Arthritis, Rheumatoid; Fluorodeoxyglucose F18; Humans; Hyperplasia; Lung; Lung Diseases; Lymphoproliferative Disorders; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed

2023
FDG-Avid But Pentixafor-Negative in EBV-Associated T-Cell Lymphoproliferative Disorders.
    Clinical nuclear medicine, 2023, Aug-01, Volume: 48, Issue:8

    Topics: Adolescent; Female; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Lymphoma; Lymphoproliferative Disorders; Positron Emission Tomography Computed Tomography; T-Lymphocytes

2023
FDG PET/CT Findings of Renal Cell Carcinoma Arising From a Transplanted Kidney in a Pediatric Patient.
    Clinical nuclear medicine, 2023, Dec-01, Volume: 48, Issue:12

    Topics: Carcinoma, Renal Cell; Child; Female; Fluorodeoxyglucose F18; Humans; Kidney; Kidney Neoplasms; Kidney Transplantation; Lymphoproliferative Disorders; Positron Emission Tomography Computed Tomography

2023
Diagnostic performance of FDG-PET/CT of post-transplant lymphoproliferative disorder and factors affecting diagnostic yield.
    European journal of nuclear medicine and molecular imaging, 2020, Volume: 47, Issue:3

    Topics: Epstein-Barr Virus Infections; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Lymphoproliferative Disorders; Positron Emission Tomography Computed Tomography; Retrospective Studies

2020
    European journal of nuclear medicine and molecular imaging, 2020, Volume: 47, Issue:3

    Topics: Fluorodeoxyglucose F18; Humans; Lymphoproliferative Disorders; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography

2020
Post-heart transplantation lymphoproliferative diseases (PTLDs) and the diagnostic role of [18f] FDG-PET/CT.
    Minerva medica, 2021, Volume: 112, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Heart Transplantation; Hodgkin Disease; Humans; Hyperplasia; Immunocompromised Host; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Postoperative Complications; Radiopharmaceuticals

2021
Acute Brain Stroke Evolution Detected by 18F-FDG PET/CT and MRI Justifies the Discordance of Lesions in a Patient With Lymphoproliferative Syndrome.
    Clinical nuclear medicine, 2021, 03-01, Volume: 46, Issue:3

    Topics: Diagnosis, Differential; Disease Progression; Fluorodeoxyglucose F18; Humans; Lymphoproliferative Disorders; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Stroke

2021
FDG-PET/CT findings of chronic active Epstein-Barr virus infection.
    Leukemia & lymphoma, 2018, Volume: 59, Issue:6

    Topics: Bone Marrow; Epstein-Barr Virus Infections; Fluorodeoxyglucose F18; Herpesvirus 4, Human; Humans; Lymph Nodes; Lymphoproliferative Disorders; Positron Emission Tomography Computed Tomography

2018
18F-FDG PET for Detection of Primary Tracheobronchial T-/Natural Killer-Cell-Derived Posttransplant Lymphoproliferative Disorder After Lung Transplantation.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:12

    Topics: Bronchi; Fluorodeoxyglucose F18; Humans; Lung Transplantation; Lymphoproliferative Disorders; Male; Natural Killer T-Cells; Positron-Emission Tomography; Trachea; Young Adult

2017
End-of-Treatment Positron Emission Tomography After Uniform First-Line Therapy of B-Cell Posttransplant Lymphoproliferative Disorder Identifies Patients at Low Risk of Relapse in the Prospective German PTLD Registry.
    Transplantation, 2018, Volume: 102, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; B-Lymphocytes; Contrast Media; Disease Progression; Female; Fluorodeoxyglucose F18; Germany; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Middle Aged; Neoplasm Staging; Organ Transplantation; Positron-Emission Tomography; Predictive Value of Tests; Progression-Free Survival; Recurrence; Registries; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Young Adult

2018
FDG PET/CT Findings of Polymorphic Posttransplant Lymphoproliferative Disorders in a Transplanted Kidney.
    Clinical nuclear medicine, 2018, Volume: 43, Issue:6

    Topics: Female; Fluorodeoxyglucose F18; Humans; Kidney Transplantation; Liver Transplantation; Lymphoproliferative Disorders; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals

2018
FDG PET/CT in 2 Cases of Hepatic Pseudolymphoma.
    Clinical nuclear medicine, 2018, Volume: 43, Issue:5

    Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Liver; Lymphoproliferative Disorders; Middle Aged; Positron Emission Tomography Computed Tomography; Pseudolymphoma; Radiopharmaceuticals

2018
Adalimumab-Induced Epstein-Barr Virus-Related Lymphoproliferative Disorder on FDG PET/CT.
    Clinical nuclear medicine, 2018, Volume: 43, Issue:5

    Topics: Adalimumab; Antirheumatic Agents; Arthritis, Psoriatic; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Humans; Lymphoproliferative Disorders; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals

2018
Extreme hypercalcemia in a kidney transplant recipient.
    CEN case reports, 2018, Volume: 7, Issue:2

    Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Everolimus; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Hypercalcemia; Kidney Transplantation; Lymphoproliferative Disorders; Male; Positron-Emission Tomography; Prednisone; Renal Dialysis; Rituximab; Shock, Septic; Transplant Recipients; Vincristine

2018
Sclerosing mesenteritis by Mycobacterium Genavense mimicking a lymphoproliferative syndrome: The value of
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2019, Volume: 51, Issue:10

    Topics: Adult; Computed Tomography Angiography; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoproliferative Disorders; Male; Mycobacterium; Mycobacterium Infections; Panniculitis, Peritoneal; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals

2019
18F-fluorodeoxyglucose positron emission tomography in elderly patients with an elevated erythrocyte sedimentation rate of unknown origin.
    PloS one, 2013, Volume: 8, Issue:3

    Topics: Aged; Aged, 80 and over; Blood Sedimentation; Brain; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lymphoproliferative Disorders; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Retrospective Studies; Tomography, X-Ray Computed

2013
(18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis of post-transplant lymphoproliferative disorder.
    Leukemia & lymphoma, 2014, Volume: 55, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Female; Fluorodeoxyglucose F18; Humans; Lymphoproliferative Disorders; Male; Middle Aged; Organ Transplantation; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult

2014
Epstein-Barr DNA serology and positron-emission tomography imaging of the head and neck in pediatric transplant recipients.
    The Laryngoscope, 2014, Volume: 124, Issue:5

    Topics: Child; Child, Preschool; Contrast Media; DNA, Viral; Epstein-Barr Virus Infections; Female; Fluorodeoxyglucose F18; Graft Rejection; Head; Humans; Infant; Liver Transplantation; Lymphoproliferative Disorders; Male; Multimodal Imaging; Neck; Polymerase Chain Reaction; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed

2014
(18)F-FDG PET/CT in the management of patients with post-transplant lymphoproliferative disorder.
    Nuclear medicine communications, 2014, Volume: 35, Issue:3

    Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Infant; Lymphoproliferative Disorders; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed; Transplantation; Young Adult

2014
FDG PET/CT Findings of the Recurrent Posttransplantation Lymphoproliferative Disorder in a Pediatric Liver Transplant Recipient With Right Leg Pain as the Only Complaint.
    Clinical nuclear medicine, 2015, Volume: 40, Issue:10

    Topics: Child; Female; Fluorodeoxyglucose F18; Humans; Leg; Liver Transplantation; Lymphoproliferative Disorders; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed

2015
Posttransplant Lymphoproliferative Disorder of the Thorax: CT and FDG-PET Features in a Single Tertiary Referral Center.
    Medicine, 2015, Volume: 94, Issue:31

    Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lymphoproliferative Disorders; Male; Middle Aged; Organ Transplantation; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tertiary Care Centers; Thorax; Tomography, X-Ray Computed

2015
The value of 18F-FDG PET in pediatric patients with post-transplant lymphoproliferative disorder at initial diagnosis.
    Pediatric transplantation, 2015, Volume: 19, Issue:8

    Topics: Adolescent; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymphoproliferative Disorders; Male; Multimodal Imaging; Organ Transplantation; Positron-Emission Tomography; Postoperative Complications; Radiopharmaceuticals; Retrospective Studies; Tomography, X-Ray Computed

2015
The usefulness of (18)F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD).
    BMC cancer, 2016, 08-15, Volume: 16

    Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Tumor Burden

2016
Protocol considerations for positron emission tomography-computed tomography of the abdomen and pelvis.
    Seminars in ultrasound, CT, and MR, 2008, Volume: 29, Issue:4

    Topics: Abdominal Neoplasms; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Genital Neoplasms, Female; Humans; Lymphoma; Lymphoproliferative Disorders; Pancreatic Neoplasms; Pelvic Neoplasms; Positron-Emission Tomography; Sarcoma; Stomach Neoplasms; Tomography, X-Ray Computed

2008
FDG-PET/CT imaging in the management of HIV-associated multicentric Castleman's disease.
    European journal of nuclear medicine and molecular imaging, 2009, Volume: 36, Issue:4

    Topics: Adult; Anti-Retroviral Agents; Castleman Disease; Female; Fluorodeoxyglucose F18; HIV Infections; Humans; Lymph Nodes; Lymphoproliferative Disorders; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Tomography, X-Ray Computed

2009
PET/CT staging and response evaluation of post-transplantation lymphoproliferative disease (PTLD).
    Clinical nuclear medicine, 2009, Volume: 34, Issue:6

    Topics: Adult; Fluorodeoxyglucose F18; Humans; Kidney Transplantation; Lymphoproliferative Disorders; Male; Positron-Emission Tomography; Tomography, X-Ray Computed

2009
Nodular lymphoid hyperplasia: rare case of lymphoproliferative disease in the lung.
    General thoracic and cardiovascular surgery, 2009, Volume: 57, Issue:6

    Topics: Adolescent; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases; Lymphoproliferative Disorders; Pneumonectomy; Positron-Emission Tomography; Pseudolymphoma; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome

2009
Positron emission tomography in the diagnosis and therapeutic monitoring of post-transplant lymphoproliferative disorder after cord blood transplantation.
    Bone marrow transplantation, 2010, Volume: 45, Issue:3

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Cord Blood Stem Cell Transplantation; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Leukemia, Myeloid, Acute; Lymphoproliferative Disorders; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Rituximab; Tomography, X-Ray Computed; Transplantation, Homologous

2010
Ocular adnexal IgG4-related lymphoplasmacytic infiltrative disorder.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2010, Volume: 128, Issue:5

    Topics: Adult; Aged; Conjunctival Diseases; Eyelid Diseases; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Immunoglobulin G; Immunohistochemistry; In Situ Hybridization; Lymphoproliferative Disorders; Magnetic Resonance Imaging; Male; Middle Aged; Plasma Cells; Positron-Emission Tomography; Prospective Studies; Pseudolymphoma; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult

2010
F-18 FDG PET/CT findings of a case of sacral nerve root neurolymphomatosis that occurred during chemotherapy.
    Clinical nuclear medicine, 2011, Volume: 36, Issue:1

    Topics: Breast Neoplasms; Drug-Related Side Effects and Adverse Reactions; Female; Fluorodeoxyglucose F18; Humans; Lymphoproliferative Disorders; Middle Aged; Positron-Emission Tomography; Sacrum; Spinal Nerve Roots; Tomography, X-Ray Computed

2011
FDG PET/CT in a patient with spontaneous remission of methotrexate-associated lymphoproliferative disorders after interruption of methotrexate.
    Clinical nuclear medicine, 2011, Volume: 36, Issue:7

    Topics: Aged; Fluorodeoxyglucose F18; Humans; Lymphoproliferative Disorders; Male; Methotrexate; Positron-Emission Tomography; Remission, Spontaneous; Tomography, X-Ray Computed

2011
Usefulness of F-18 FDG PET/CT in the evaluation of neck swelling in polymorphic posttransplant lymphoproliferative disorder after renal transplantation.
    Clinical nuclear medicine, 2011, Volume: 36, Issue:7

    Topics: Adult; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Inflammation; Kidney Transplantation; Lymphoproliferative Disorders; Male; Neck; Positron-Emission Tomography; Tomography, X-Ray Computed; Ultrasonography; Whole Body Imaging

2011
Posttransplantation lymphoproliferative disorder involving liver after renal transplantation.
    The Korean journal of hepatology, 2011, Volume: 17, Issue:2

    Topics: Adolescent; Biopsy, Fine-Needle; Fluorodeoxyglucose F18; Glomerulosclerosis, Focal Segmental; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver; Lymphoproliferative Disorders; Male; Positron-Emission Tomography; Tomography, X-Ray Computed; Ultrasonography

2011
Both native and ectopically transplanted hearts shown on FDG PET/CT in a PTLD patient.
    Clinical nuclear medicine, 2012, Volume: 37, Issue:10

    Topics: Female; Fluorodeoxyglucose F18; Heart; Heart Transplantation; Humans; Immunosuppression Therapy; Lymphoproliferative Disorders; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult

2012
The accuracy of positron emission tomography in the detection of posttransplant lymphoproliferative disorder.
    Haematologica, 2013, Volume: 98, Issue:5

    Topics: Adult; Biopsy; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Humans; Lymphoproliferative Disorders; Male; Middle Aged; Organ Transplantation; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Time Factors

2013
Gallium-67 scintigraphy and f-18 fluorodeoxyglucose position emission tomography in posttransplant lymphoproliferative disorder.
    Clinical nuclear medicine, 2004, Volume: 29, Issue:5

    Topics: Adult; Burkitt Lymphoma; Fluorodeoxyglucose F18; Gallium Radioisotopes; Heart Transplantation; Humans; Lymphoproliferative Disorders; Male; Postoperative Complications; Tomography, Emission-Computed

2004
Positron emission tomography with fluoro-2-deoxy-D-glucose (FDG-PET) in the staging of post transplant lymphoproliferative disorder in lung transplant recipients.
    Journal of thoracic imaging, 2004, Volume: 19, Issue:2

    Topics: Fluorodeoxyglucose F18; Humans; Lung Transplantation; Lymphoproliferative Disorders; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed

2004
FDG PET imaging in the evaluation of post-transplant lymphoproliferative disorder following renal transplantation.
    Nuclear medicine communications, 2005, Volume: 26, Issue:12

    Topics: Adolescent; Adult; Biopsy; Child; Female; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphoproliferative Disorders; Male; Positron-Emission Tomography; Postoperative Complications; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole-Body Counting

2005
Posttransplant lymphoproliferative disorder in a lung transplant recipient.
    Journal of thoracic imaging, 2005, Volume: 20, Issue:4

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Biopsy; Epstein-Barr Virus Infections; Fluorodeoxyglucose F18; Humans; Lung Transplantation; Lymphoproliferative Disorders; Male; Postoperative Complications; Radiopharmaceuticals; Rituximab; Tomography, Emission-Computed; Tomography, X-Ray Computed

2005
Post transplant lymphoproliferative disease in pediatric solid organ transplant patients: a possible role for [18F]-FDG-PET(/CT) in initial staging and therapy monitoring.
    European journal of radiology, 2007, Volume: 63, Issue:3

    Topics: Adolescent; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Lymphoproliferative Disorders; Male; Organ Transplantation; Positron-Emission Tomography; Postoperative Complications; Radiopharmaceuticals; Retrospective Studies

2007
Bone marrow necrosis complicating post-transplant lymphoproliferative disorder: resolution with rituximab.
    Leukemia research, 2008, Volume: 32, Issue:5

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Bone Marrow; Fluorodeoxyglucose F18; Humans; Kidney Transplantation; Lymphoproliferative Disorders; Male; Necrosis; Positron-Emission Tomography; Rituximab; Tomography, X-Ray Computed

2008
Clinical usefulness of FDG-PET/CT scan imaging in the management of posttransplant lymphoproliferative disease.
    Transplantation, 2008, Mar-15, Volume: 85, Issue:5

    Topics: Adult; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphoproliferative Disorders; Middle Aged; Positron-Emission Tomography; Postoperative Complications; Radiopharmaceuticals; Tomography, X-Ray Computed

2008